Cargando…
Gold nanoparticles carrying or not anti-VEGF antibody do not change glioblastoma multiforme tumor progression in mice
AIMS: Glioblastoma multiforme (GBM) is the most devastating malignant primary brain tumor known. Life expectance is around 15 months after diagnosis. Several events contribute to the GBM progression such as uncontrolled genetic cancer cells proliferation, angiogenesis (mostly vascular endothelial gr...
Autores principales: | Silva, Viviane de Cassia Jesus da, Silva, Renee de Nazare O., Colli, Lucas Giglio, Carvalho, Maria Helena Catelli de, Rodrigues, Stephen Fernandes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701192/ https://www.ncbi.nlm.nih.gov/pubmed/33294714 http://dx.doi.org/10.1016/j.heliyon.2020.e05591 |
Ejemplares similares
-
Glioblastoma multiforme in childhood: a case report
por: Borgo, Mauro Cruz Machado, et al.
Publicado: (2010) -
Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018) -
VEGF Promotes Proliferation of Human Glioblastoma Multiforme Stem-Like Cells through VEGF Receptor 2
por: Xu, Chengshi, et al.
Publicado: (2013) -
hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines
por: Masi, A, et al.
Publicado: (2005) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)